The epicenter for all tobacco research at The Ohio State University
The epicenter for all tobacco research at The Ohio State University
The program supports multidisciplinary research investigations to inform federal and state tobacco regulations and expand tobacco cessation efforts across Ohio.
The goal of the Center for Tobacco Research is provide evidence-based knowledge urgently needed by the scientific community, public health officials and regulatory authorities to regulate tobacco products effectively and in a way that best serves individual and public health.
Learn MoreThe CTR team are research scientists from a myriad of backgrounds: psychology, epidemiology, biostatistics, environmental health, health communications, chemistry, biochemistry, cancer biology, law and more.
View MembersThe Center for Tobacco Research remains steadfast in the effort to raise awareness about tobacco dependence and cessation efforts while also sharing critical findings and knowledge with the public about today’s ever-evolving tobacco market place.
Learn MoreAs one of the seven Tobacco Centers of Regulatory Science identified and funded through the Food and Drug Administration and National Institutes of Health, our multi-disciplinary team of experts at the OSUCCC – James is tasked with gathering scientific evidence to help support the FDA’S potential regulation of tobacco products.
Our team conducts in-depth research on tobacco, trains future professionals in regulatory science and actively monitors the tobacco industry for the latest product trends and overall economic impact.
Ohio State's Center for Tobacco Research is working to create a cancer-free world. Get involved today.
Interested in collaborating on research or learning more? Contact the Center for Tobacco Research today.
Contact UsFind out more about current research opportunities, study requirements and protocols through the Center for Tobacco Research.
Sign Up TodayWe are dedicated to training the next generation of tobacco researchers. Join us today.
Learn MoreOhio State's Center for Tobacco Research has been featured in a number of news articles and educational videos involving their work with tobacco research.
San Diego middle school student Sydney Mafong was a finalist at the 2021 National History Day competition in California for her documentary, "Blowing Smoke," which analyses the communication practices of tobacco companies and their motivations and outcomes.
In August, the U.S. Food and Drug Administration proposed a rule to require 13 new warnings for cigarette packages and advertisements. The rule would place images on tobacco materials that warn of risks like cancer or heart disease, which would help spread important information to the general public. Many countries have already required such “graphic warnings.”
Need some tips on how to quit juul? First, see your doctor — he or she can give you a complete check-up to look for any signs of vaping-related illness. Also, try these surprising tips and tricks to stay on track — soon you’ll be breathing so much easier!
Juul executives knew young people were flocking to its breakthrough e-cigarette shortly after it went on sale in 2015, a former manager tells Reuters. Its nicotine blend was so potent, engineers devised a kill switch to limit the dosage — but the idea was shelved.
Ohio State experts are making a case for why the U.S. Food and Drug Administration’s (FDA) proposed rule to add 13 new graphic warnings for cigarette packages and advertisements should be allowed to go into effect.
At any given time, numerous scientific, advanced research projects are in progress in the CTR – all designed to assess the biological,
psychological, economic and public health implications associated with tobacco use and the industry’s marketing of products to consumers.
E-cigarette use is rising at concerning levels among both smokers and non-smokers, and new research data suggests that even short-term e-cig use can cause cellular inflammation in never-smoker adults. OSUCCC – James researchers report the first evidence of biological changes correlated with e-cig use in never-smokers in the journal Cancer Prevention Research.
New research reported in the New England Journal of Medicine by the Centers for Disease Control and Prevention (CDC) in collaboration with the OSUCCC – James strengthens prior findings on the link between vitamin E acetate and EVALI (E-cigarette or vaping product use-associated lung injury).
People who vape and smoke cigarettes are no more likely to drop the nicotine habit than those who just smoke, a new Ohio State study suggests.
A new study shows that so-called “light” cigarettes have no health benefits to smokers and have likely contributed to the rise of a certain form of lung cancer that occurs deep in the lungs.
Researchers with the OSUCCC – James and College of Public Health are looking for approximately 2,000 families to participate in a study aimed at understanding why people start using tobacco and how tobacco use changes overtime.
Is vaping creating a new generation of smokers and increasing the cancer risk? Ted Wagener, PhD, director of the Center for Tobacco Research at the OSUCCC – James, tackles this question and other important, related issues: why nicotine is so addictive; cessation strategies; and the history of vaping. He discusses whether vaping is safe and/or safer than cigarettes, whether it is reducing the number of smokers, why flavored e-cigs are so dangerous, the long-term health implications of vaping and how researchers are studying this. Ted is a former smoker and understands the addictive power of nicotine.
Is vaping creating a new generation of smokers and increasing the cancer risk? Ted Wagener, PhD, director of the Center ...
read moreGet to know some of the CTR research scientists and tobacco experts.
My research examines how public health research can assist in tobacco regulatory policy and explores how legal doctrines facilitate or limit public health interventions, particularly those relating to cancer prevention.
My research focuses on the economic analysis of health behaviors, with an emphasis on how taxes and policies impact substance use and abuse.
I am a pediatric psychologist and assistant professor in the Division of Medical Oncology at The Ohio State University.
I am associate professor of Medical Oncology and Assistant Dean for Research and Tenure Track Faculty at the Ohio State University College of Medicine, and Director of Training in the Center for Tobacco Research at the Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
I am an Organic/Analytical chemist that went from fundamental organometallic chemistry research to being interested in the assessment of human exposure to toxicants from various sources, especially tobacco products.
My current research program focuses on identifying key characteristics of marketing and health communications that influence consumer's risk perceptions and use of nicotine and tobacco.